WBA (Walgreens Boots Alliance) Risk Assessment

View and export this data going back to 1985. Start your Free Trial

What is Walgreens Boots Alliance Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Walgreens Boots Alliance is: High Risk: High uncertainty.

Competitive Comparison of Walgreens Boots Alliance's Risk Assessment

For the Pharmaceutical Retailers subindustry, Walgreens Boots Alliance's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Walgreens Boots Alliance's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Walgreens Boots Alliance's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Walgreens Boots Alliance's Risk Assessment falls into.

Save Embed

;

Save Embed

;

Walgreens Boots Alliance (NAS:WBA) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Walgreens Boots Alliance Risk Assessment Related Terms

Thank you for viewing the detailed overview of Walgreens Boots Alliance's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Walgreens Boots Alliance Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Walgreens Boots Alliance Inc (NAS:WBA) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

WBA:Mexico 1WBA:Italy W8Ad:UK 0LSZ:UK W8A:Germany W8A:Germany W8A:Germany WGBA34:Brazil WBA:Austria

Address

108 Wilmot Road, Deerfield, IL, USA, 60015

Website

https://www.walgreensbootsalliance.com

Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.

Executives

Inderpal S Bhandari	director	C/O WALGREENS BOOTS ALLIANCE, INC., DEERFIELD IL 60015
Manmohan Mahajan	officer: SVP, Global Controller and CAO	C/O WALGREENS BOOTS ALLIANCE, INC., 108 WILMOT ROAD, DEERFIELD IL 60015
Nancy M Schlichting	director	200 WILMOT ROAD, DEERFIELD IL 60015
Timothy C Wentworth	director, officer: Chief Executive Officer	C/O EXPRESS SCRIPTS HOLDING COMPANY, ONE EXPRESS WAY, ST. LOUIS MO 63121
Richard P. Gates	officer: SVP, Chief Pharmacy Officer	C/O WALGREENS BOOTS ALLIANCE, INC., 108 WILMOT ROAD, DEERFIELD IL 60015
Neal J. Sample	officer: EVP, Chief Information Officer	200 VESEY STREET, NEW YORK NY 10285
Todd Heckman	officer: Interim Global Controller	C/O WALGREENS BOOTS ALLIANCE, INC., 108 WILMOT ROAD, DEERFIELD IL 60015
Polen Thomas E Jr	director	BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
John Patrick Driscoll	officer: EVP, Pres. U.S. Healthcare	C/O WALGREENS BOOTS ALLIANCE, INC., 108 WILMOT ROAD, DEERFIELD IL 60015
Rosalind G Brewer	director, officer: CEO	C/O MOLSON COORS BREWING COMPANY, 1225 17TH STREET, SUITE 3200, DENVER CO 80202
Kevin M. Ban	officer: EVP, Chief Medical Officer	C/O WALGREENS BOOTS ALLIANCE, INC., 108 WILMOT ROAD, DEERFIELD IL 60015
Bryan C Hanson	director	ZIMMER BIOMET HOLDINGS, 345 E. MAIN STREET, WARSAW IN 46580
Henry Lee Cooper	officer: EVP, Pres. Walgreens Pharmacy	C/O WALGREENS BOOTS ALLIANCE, INC., 108 WILMOT ROAD, DEERFIELD IL 60015
Tracey D Brown	officer: SVP, Pres., Walgreens Retail	675 AVENUE OF THE AMERICAS, 6TH FLOOR, NEW YORK NY 10010
Steven J Shulman	director	1564 NE EXPRESSWAY, ATTN: BJ PURCELL, ATLANTA GA 30329